Heart Attack News and Research

RSS

Friends and family could be the cure for work related stress

On-the-job stress can increase your blood pressure, adding to your risk of having a heart attack or stroke, according to evidence from two new studies by Heart and Stroke Foundation researchers.

26 Oct 2004

Blood pressure at the high end of normal still a risk for heart disease

If you’re male, and your systolic blood pressure is a little bit on the high side, even though it is still within the normal range, you could be at an increased risk of having heart attack compared to men whose systolic blood pressure is on the low end of normal, Heart and Stroke Foundation researchers say.

26 Oct 2004

Following the withdrawal of Vioxx, the European Medicines Agency has been asked to review of COX-2 inhibitor medicines

Following the worldwide withdrawal of Vioxx (rofecoxib), the European Medicines Agency (EMEA) has been asked by the European Commission, as a precautionary measure, to conduct a review of COX-2 inhibitor medicines.

25 Oct 2004

To avoid metabolic syndrome is relatively simple – 30 minutes of physical activity once a week

Metabolic syndrome is a condition that is affecting thousands of Canadians and is putting them at risk of heart disease and stroke, especially those aged 50 and over.

25 Oct 2004

Gene variations explain why people with type 2 diabetes are at much greater risk for coronary artery disease

New studies by an international team of scientists led by Joslin Diabetes Center have found variations in a gene that help explain why people with type 2 diabetes are at much greater risk for coronary artery disease, the leading cause of death for this group.

21 Oct 2004

Early reports of thrombosis after insertion of drug-eluting stent

Authors of a research letter in this week’s issue of THE LANCET highlight how the use of drug-eluting stents (DES) may carry a risk of subsequent thrombosis if stenting is accompanied by a withdrawal of antiplatelet therapy.

21 Oct 2004

Researchers have developed a novel drug-antidote pair

In a discovery that could give physicians more control over the actions of medications, researchers at Duke University Medical Center have developed a novel drug pair – a potent anti-coagulant with a matched "antidote."

18 Oct 2004

Study links possible role of ephedrine in sudden cardiac arrests

Each year 80,000 - 100,000 people in the U.S die suddenly from heart attacks without ever having had any symptoms of heart disease. In some cases, the victims of these unheralded sudden cardiac deaths had been taking dietary supplements containing ephedrine.

16 Oct 2004

People who drank alcohol on a regular basis appeared to have less cardiovascular disease

Many previous studies have shown a link between moderate alcohol consumption, versus abstinence or heavy consumption, and decreased mortality from cardiovascular disease.

16 Oct 2004

Single protein appears central to the formation of the long-term memories

Researchers at the National Institute of Child Health and Human Development have discovered that a single protein appears central to the formation of the long-term memories.

16 Oct 2004

New online resource helps people diagnosed with depression

People diagnosed with depression can now find out more about the condition by listening to the experiences of others, thanks to a new online resource launched on Friday 8 October by the Database of Individual Patient Experiences (DIPEx).

12 Oct 2004

Biomarker called cystatin C predicts which people are less likely to survive a heart attack

A biomarker called cystatin C, which measures kidney function, predicts which people are less likely to survive a heart attack, according to research published in Circulation: Journal of the American Heart Association.

11 Oct 2004

Study increases likelihood that MRI could be used as predictive technology to determine which patients should be placed on statin therapy for atherosclerosis

Using modified magnetic resonance imaging (MRI) techniques, researchers at Johns Hopkins have been able to detect the early benefits of a cholesterol-lowering medication much sooner than before.

11 Oct 2004

Progestin in hormone therapy could dramatically affect heart attack severity

“One type of hormone therapy limited heart muscle damage to only 5 percent while another resulted in permanent damage to 35 percent of muscle,” said J. Koudy Williams, Ph.D., lead investigator, from Wake Forest Baptist. “If we can learn more about this mechanism we might be able to identify better hormone therapies for postmenopausal women.”

10 Oct 2004

Aspirin might well be considered the top utility player in the medicine cabinet

This cheap over-the-counter drug can be used not only for fever, pain and arthritis, but to prevent heart attack, stroke or angina. It also may reduce the risk of colorectal cancer. Yet aspirin also has side effects worth considering, and its very accessibility may hamper its use.

8 Oct 2004

Receiving a blood transfusion is associated with a greater risk of death for patients with acute coronary syndromes

The use of invasive procedures for treatment of ischemic heart disease has more than tripled in the past 2 decades and is likely to increase in high-risk patients, according to background information in the article.

5 Oct 2004

Black and Hispanic patients experience marked delays in heart attack treatment compared with whites

Black and Hispanic patients experience marked delays in heart attack treatment compared with whites, Yale researchers report in an article published in the October 6 Journal of the American Medical Association (JAMA).

5 Oct 2004

International society agrees that the potential of stem cells derived from fat show promising clinical uses

While questions still remain about the nature and function of stem cells found in fat, a group of researchers and clinicians convened today in Pittsburgh at the Second Annual Meeting of the International Fat Applied Technology Society (IFATS) agreed that research should move forward with the ultimate goal of performing human clinical trials to test the cells' therapeutic potential for specific indications.

5 Oct 2004

Immediate voluntary world-wide withdrawal of Vioxx (rofecoxib)

Pharmaceutical company, Merck Sharp & Dohme has announced an immediate voluntary world-wide withdrawal of the drug, Vioxx (rofecoxib), commonly used for patients with rheumatoid or osteoarthritis.

4 Oct 2004

Sibling history is a better predictor of coronary heart disease than parental history or traditional risk factor scoring

Researchers at Johns Hopkins have found that sibling history -- whether or not a brother or sister had early heart disease -- is a better predictor of a person's likelihood of developing coronary heart disease than parental history or traditional risk factor scoring.

4 Oct 2004

Heart Attack News and Research

Friends and family could be the cure for work related stress

Blood pressure at the high end of normal still a risk for heart disease

Following the withdrawal of Vioxx, the European Medicines Agency has been asked to review of COX-2 inhibitor medicines

To avoid metabolic syndrome is relatively simple – 30 minutes of physical activity once a week

Gene variations explain why people with type 2 diabetes are at much greater risk for coronary artery disease

Early reports of thrombosis after insertion of drug-eluting stent

Researchers have developed a novel drug-antidote pair

Study links possible role of ephedrine in sudden cardiac arrests

People who drank alcohol on a regular basis appeared to have less cardiovascular disease

Single protein appears central to the formation of the long-term memories

New online resource helps people diagnosed with depression

Biomarker called cystatin C predicts which people are less likely to survive a heart attack

Study increases likelihood that MRI could be used as predictive technology to determine which patients should be placed on statin therapy for atherosclerosis

Progestin in hormone therapy could dramatically affect heart attack severity

Aspirin might well be considered the top utility player in the medicine cabinet

Receiving a blood transfusion is associated with a greater risk of death for patients with acute coronary syndromes

Black and Hispanic patients experience marked delays in heart attack treatment compared with whites

International society agrees that the potential of stem cells derived from fat show promising clinical uses

Immediate voluntary world-wide withdrawal of Vioxx (rofecoxib)

Sibling history is a better predictor of coronary heart disease than parental history or traditional risk factor scoring

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News